CompletedPhase 4

Stage I Multiple Myeloma Treatment

France89 participantsStarted 2004-12

Plain-language summary

* Assessment of survival without progression of stage I MM in two groups: arm A: simple survey and arm B: administration of Zoledronate. * Describe different progression's type noticed and define the prognosis factors of a fast evolution.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * stage I multiple myeloma without bones injuries Exclusion Criteria: * abnormal kidney function * VIH infection * Hepatic incapacity * pregnancy * Associate pathology

What they're measuring

Survival without progress

Timeframe: every month during 6 years

Trial details

NCT IDNCT00733538

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-11

View on ClinicalTrials.gov More Multiple Myeloma trials